Clin2
NCT06729541Possibly a fitRecruiting

Precision treatments for common mental disorders

Depression - Major Depressive DisorderSchizophrenia DisordersBipolar Disorder (BD)

Part of Mental health clinical trials.

This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You have been diagnosed with schizophrenia, depression, or bipolar disorder
  • Your symptoms are at least moderate in severity (based on a standard rating scale)
  • You are able to read, understand, and complete questionnaires and treatments
  • You do not have severe suicidal thoughts, unstable physical illness, or certain other conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07738497Not yet recruiting
Precision treatment for depression using biomarkers

This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.

NCT07480486Not yet recruiting
Personalized antidepressant selection using genetic testing

This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.

Rabat, Rabat-Salé-Kénitra
NCT06641726Recruiting
Global database linking genetics and health records for mental illness

This trial is building a research database that combines genetic information and long-term health data to improve personalized treatment for serious mental illness. You may be eligible if you have been diagnosed or treated for depression, bipolar disorder, schizophrenia, or dementia.

Oxford, Oxford
NCT07373470Recruiting
Pharmacist help with depression meds using your DNA

This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.

Pittsburgh, Pennsylvania
NCT07649993Not yet recruiting
Gene activity markers in mental health conditions

This study looks at how certain molecules (called non-coding RNAs) relate to mental health conditions like bipolar disorder, depression, anxiety, OCD, or schizophrenia. By comparing patients who haven't been on psychiatric medication for at least 6 months with healthy volunteers, researchers hope to find better ways to diagnose and understand these conditions.

Catania, Sicily
NCT07189689Not yet recruiting
Mood disorder study for people with depression or bipolar disorder

This study is looking at people with mood disorders like depression or bipolar disorder to better understand their experiences. By joining, you can help researchers learn more about these conditions, which may lead to better care in the future.

Oxford

Hear when a new Depression - Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.